A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P） — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P） — Stella

Recruiting

Back to Drug-induced Liver Injury trials

Trial locations(1 site)

China

Renji hospital, Shanghai

Key details

Sponsor

Drug Induced Liver Disease Study Group

Enrollment target

~10,000 participants

Started

April 2016

Primary completion

December 2030

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov